A Study to Observe Treatment Patterns in Patients in Colombia Who Have Heart Failure
HEATCO
HEArt Failure Treatment Patterns: A Descriptive Study in COlombia
1 other identifier
observational
1,000
1 country
1
Brief Summary
Researchers want to learn more about the treatments doctors choose to treat heart failure. Heart failure means the heart isn't pumping as well as it should be. Heart failure can lead to other serious medical conditions, and it can lead to hospitalization or death. There are different types of treatments available for people who have heart failure, and these work in different ways. In this study, the researchers will collect information about Colombian patients who have heart failure. The main purpose of this study is to identify patterns in the treatments that doctors first prescribe to heart failure patients in Columbia. To do this, the researchers will review information from the patients' medical records and from a drug-dispensing database. The study will include adult patients who have been diagnosed with heart failure in Columbia from June 1st, 2019 to May 31st, 2020. There will be no required visits, treatments, or procedures in this study. The researchers will collect information about the treatments the patients have been prescribed by their own doctors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2021
CompletedStudy Start
First participant enrolled
August 1, 2021
CompletedFirst Posted
Study publicly available on registry
September 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2022
CompletedDecember 15, 2022
December 1, 2022
1.3 years
July 19, 2021
December 14, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Treatment initiation patterns
Treatment initiation patterns of patients with Heart Failure (HF) in an outpatient setting from Colombia.
Database analysis: HF patients from June 1st, 2019 to May 31st, 2020
Secondary Outcomes (16)
Clinical characteristics at baseline - Symptoms and signs: Dyspnea
Database analysis: HF patients from June 1st, 2019 to May 31st, 2020
Clinical characteristics at baseline - Symptoms and signs: Fatigue
Database analysis: HF patients from June 1st, 2019 to May 31st, 2020
Clinical characteristics at baseline - Symptoms and signs: Lower limb edema
Database analysis: HF patients from June 1st, 2019 to May 31st, 2020
Clinical characteristics at baseline - Laboratory data: Hemoglobin and hematocrit level
Database analysis: HF patients from June 1st, 2019 to May 31st, 2020
Clinical characteristics at baseline - Laboratory data: Left ventricular ejection fraction (LVEF)
Database analysis: HF patients from June 1st, 2019 to May 31st, 2020
- +11 more secondary outcomes
Study Arms (1)
Heart Failure (HF) patients
Patients diagnosed with incident HF, in an outpatient setting in Colombia during the time period of 01 JUN 2019 to 31 MAY 2020
Interventions
Treatment initiation patterns of patients with Heart Failure (HF) in an outpatient setting from Colombia.
Eligibility Criteria
Patients diagnosed with incident HF, in an outpatient setting in Colombia during the time period of 01 JUN 2019 to 31 MAY 2020. The universe of the study corresponds to all individuals who are identified in the database as having HF diagnosed by ICD-10 code in the prescription; the target population corresponds to subjects who were diagnosed and prescribed with a HF treatment at the selected health insurance company and whose prescriptions were filled in Audifarma.
You may qualify if:
- Adult patients (older than 18 years) with a diagnosis of HF according to ICD-10 with a dispensing of some medicine and it is registered in the database of Audifarma S.A. during the observation period will be included
You may not qualify if:
- Patients with Acute HF without prior diagnosis of HF
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayerlead
Study Sites (1)
Many Locations
Multiple Locations, Colombia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2021
First Posted
September 8, 2021
Study Start
August 1, 2021
Primary Completion
November 16, 2022
Study Completion
November 16, 2022
Last Updated
December 15, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share
Availability of this study's data will later be determined according to Bayer's commitment to the EFPIA/PhRMA "Principles for responsible clinical trial data sharing". This pertains to scope, timepoint and process of data access. As such, Bayer commits to sharing upon request from qualified researchers patient-level clinical trial data, study-level clinical trial data, and protocols from clinical trials in patients for medicines and indications approved in the US and EU as necessary for conducting legitimate research. This applies to data on new medicines and indications that have been approved by the EU and US regulatory agencies on or after January 01, 2014. Interested researchers can use www.clinicalstudydatarequest.com to request access to anonymized patient-level data and supporting documents from clinical studies to conduct research. Information on the Bayer criteria for listing studies and other relevant information is provided in the Study sponsors section of the portal.